Found 4 matching trials
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
PHASE1This is a multicenter, open-label, dose-escalation and dose-expansion study...
Location
James Graham Brown Cancer Center
Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody
PHASE2The development of Auto Immune bullous Diseases (AIBD) results from a compl...
Location
CHU de Nice- Dermatologie
Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )
PHASE2The primary objective of this trial is to improve the proportion of COVID-1...
Location
Assistance Publique Hôpitaux de Marseille
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection
PHASE2A prospective, controlled, randomized, multicenter study whose goal is to c...
Location
Centre Léon Bérard